DE NOVO THIRD PARTY HLA ANTIBODIES SYNERGIZE WITH DE NOVO DONOR SPECIFIC HLA ANTIBODIES TO NEGATIVELY IMPACT LUNG ALLOGRAFT OUTCOME

被引：0
|
作者：
Zhang, Aiwen [1 ]
Good, Derek J. [1 ]
Thomas, Dawn M. [1 ]
Walendzik, Allison [1 ]
Cagahastian, Van [1 ]
Allen, Jeffrey [1 ]
McMichael, John [1 ]
McCurry, Kenneth [2 ]
Budev, Marie [2 ]
Gebel, Howard M. [3 ]
Bray, Robert A. [3 ]
机构：
[1] Cleveland Clin, Allogen Labs, Cleveland, OH 44106 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
来源：
HUMAN IMMUNOLOGY | 2019年 / 80卷
关键词：
D O I：
10.1016/j.humimm.2019.07.027
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OR25
引用
收藏
页码：32 / 33
页数：2
相关论文
共 50 条
  • [1] PERSISTENCE OF DE NOVO DONOR SPECIFIC HLA-ANTIBODIES INCREASES THE RISK OF LUNG ALLOGRAFT DYSFUNCTION
    Schmitzer, M.
    Kneidinger, N.
    Dick, A.
    Neurohr, C.
    von Dossow, V.
    Schramm, R.
    Winter, H.
    Kauke, T.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 14 - 15
  • [2] EFFECT OF IMMUNE MONITORING OF DE NOVO HLA DONOR SPECIFIC ANTIBODIES (DNDSA) IN RENAL ALLOGRAFT RECIPIENTS
    Jain, Monika
    Bhargava, Vinant
    Gupta, Anurag
    Malik, Manish
    Gupta, Ashwani
    Bhalla, Anil K.
    Rana, Devinder S.
    Singh, Ravi Kumar
    HLA, 2020, 95 (04) : 311 - 311
  • [3] Below the WaterlineuThe Danger of De Novo Donor-Specific HLA Antibodies
    Kokko, K. E.
    Colvin, R. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) : 1077 - 1078
  • [4] THE IMPACT OF DE NOVO DONOR SPECIFIC ANTIBODIES AND HLA HISTOCOMPATIBILITY IN LONGTERM KIDNEY TRANSPLANTATION OUTCOME (UP TO 27 YEARS)
    Fylaktou, Asimina
    Kasimatis, Efstratios
    Karampatakis, Theodoros
    Schoina, Maria
    Anastasiou, Aikaterini
    Boukla, Anna
    Nikolaidou, Vasiliki
    Papachristou, Marianthi
    Chronis, Theodoros
    Papagianni, Aikaterini
    HLA, 2018, 91 (05) : 357 - 358
  • [5] The Impact of De Novo Donor Specific Anti-HLA Antibodies on the 5-Year Renal Transplant Outcome
    Banasik, M.
    Boratynska, M.
    Koscielska-Kasprzak, K.
    Zabinska, M.
    Chudoba, P.
    Patrzalek, D.
    Halon, A.
    Klinger, M.
    TRANSPLANTATION, 2012, 94 (10) : 1051 - 1051
  • [6] De novo production of anti-HLA donor specific antibodies during acute renal allograft rejection
    Crespo, M
    Pascual, M
    Tolkoff-Rubin, N
    Duan, JM
    Fitzpatrick, D
    Collins, AB
    Cosimi, AB
    Colvin, R
    Saidman, SL
    TRANSPLANTATION, 1999, 67 (07) : S87 - S87
  • [7] Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients
    Jalalonmuhali, M.
    Carroll, R. P.
    Tsiopelas, E.
    Clayton, P.
    Coates, P. T.
    HUMAN IMMUNOLOGY, 2020, 81 (07) : 323 - 329
  • [8] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES: BIOMARKERS OF PANCREAS TRANSPLANT FAILURE
    Mittal, Shruti
    Page, Suzanne L.
    Gilbert, James
    Friend, Peter J.
    Sharples, Edward
    Fuggle, Susan V.
    TISSUE ANTIGENS, 2013, 81 (05): : 274 - 274
  • [9] De Novo Donor-Specific HLA Antibodies: Biomarkers of Pancreas Transplant Failure
    Mittal, S.
    Page, S. L.
    Friend, P. J.
    Sharples, E. J.
    Fuggle, S. V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (07) : 1664 - 1671
  • [10] Negative Impact of De Novo Donor-Specific Anti-HLA Antibodies (De Novo DSA) after Living Donor Kidney Transplantation.
    Omoto, Kazuya
    Ishida, Hideki
    Shimizu, Tomokazu
    Shirakawa, Hiroki
    Toki, Daisuke
    Iida, Shouichi
    Tokita, Daisuke
    Furusawa, Miyuki
    Tanabe, Kazunari
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 585 - 585
12345